Member Info for Swissydog

PP I hadn't really considered that but it would be a clever move at a higher sp knowing that there are many buyers ready to jump in. The MM could be testing how far they can push it up right now to get a feel for the price that people are currently valuing the business at. Dare you post this on the HEX BB for a laugh....I dare you lol!

PP I hadn't really considered that but it would be a clever move at a higher sp knowing that there are many buyers ready to jump in. The MM could be testing how far they can push it up right now to get a feel for the price that people are currently valuing the business at. Dare you post this on the HEX BB for a laugh....I dare you lol!

Hex on a run again just asI was trying together a quote to buy at 24.5p.I hate missing out but also don't want to buy a spike. So difficult to decide when you missed the rise from 20p Mmmmmm what to do?

Not sure what the MM are doing as once again could only buy £3k first thing this morning and now is £1K?

And now the max is £1k??????

What can you buy at the moment KR as I can still only buy a max of £3k KR? Weird after yesterdays decline in SP. Still offering around 6.5p.

It could drift on low vols KR but upside will come if you are prepared for a wait. I just tried an early purchase and £3k max available still.

Obviously the last raise was at 5p so support should be there or just above. Don't forget that the last sp rally was due to the RNS on NICE recommendation for ROCA test and not FDA approval and has already had licence agreements in Austria and one other country in Europe as well as UK and at any time another AHSN NHS region could come on stream using Lipidincode and Cardioincode introduction should start this year as well. Any news will stimulate the sp even before FDA approval comes in.

I really believe that FDA approval will be in Q3 as Matthew Walls did say that under the original expected timelines he would have thought that approval would be in the next month however this timescale would not be reached and now it will be going into Q3. As he ultimately has no control over any given date he then said it is expected around Q3 as that is all he can say at this point. Have a listen on Investor Meet site as it comes in at 29mins 30 seconds in and see what you think?

I still love the products the BOD are a breath of fresh air and highly professional and I will add when I can.

To be honest LW I haven't really done much research into genedrive so I can't comment.

I think that Geni dropped today because of the way that Matthew Walls commented on the FDA application to date. He said that under the original expectations then there was 1 month left before expected news but there was a lot of details to go through and that this period will extend and run into Q3. He then later closed that part of the presentation and in summary said that news should come around Q3. People on the BB picked up on this and said that it could be months away and so the doubt spreads. We won't know for sure but it is down to interpretation.

Just a bit of wild speculation but with Matthew Walls saying that collaborations might be considered and todays price action without being able to buy any volume what so ever ( the largest buy all day was £3400 with everything else below£1k or just a few quid) it makes you wonder if a background buyer or hidden 'collaborator' could be trying to slowly take a position. Obviously no evidence for this but will be strange if I try a volume trade in the morning and similar happens I will think that something is up!

No luck there PP I'm afraid! The BOD are saying Q3 and from the graphics during presentation it indicated early Q3 but there again why wouldn't it! If you took a suggested straight forward 150 De Novo as stated on the website and you add holidays and weekends to that figure then it runs until 26th June. There is a slight delay now pushing into Q3 but just as important were the comments on funding. They are in advanced talks with 4 more NHS regions for Lipidincode (each could add £40-50K month in revenues), Germany is in initial stages but following our NHS model, Italy has come on-line, also expansions in Spain which includes Cardioincode and the first Tier one institutions in US have on-boarded and ordering Cardioincode but processed through out CLIA Lab in California. Don't forget that the FDA approval is foe CIC Kit which can be processed through other institutions CLIA Labs, hence allowing a rapid expansion. The management are holding costs back until approval (was £750K now £400K / Month) and said if or when funding was needed then they would look at all methods but would probably look at capital loans or collaborations (Matthew Walls said he may be able to talk about these possible collaborations in the near term!) but any funding would be a 'Light Touch' in comparison to the revenues being generated at that specific time. Final negotiations for insurance pay outs for Cardioincode after approval are currently between $500 and $760 / test but the BOD are negotiating hard, although either figure gives good margins.

LipidinCode will be our money maker this year as it is the most detailed test with the quickest turn around 5-7 days and highly cost effective and our SITAB system is winning acclaim as the results are sent straight back to the consultants portals and the system is exactly the same for every country of operation.

This company is building strength from its base and that takes time but I'm guessing that a nice entry could be available to late comers with the slight FDA delay. The only problem is trying to get a quote for nay volume today.

Myself plus another trader I know were trying for the whole last hour to buy on two different platforms and just could not buy any volume in fact the most I got offered was £500 and £200 respectively yet the sp offered was slightly below that shown above!!!

The company is well managed and it tries its hardest to do what it says on the tin but the FDA as in most cases can take its time. Those that can't wait go and make it elsewhere and very good luck but there could be some nicely priced shares available for those that care. Best of luck to everyone and I mean that sincerely, cheers Swissy

£500 for 6.5p so it dropped but you still couldn't buy any volume!!!

I could buy £500 max just a second ago!

KR it is because FDA approval are now going into Q3 and this is AIM and people can't wait. There is a small free float and movements are big on little activity. Look at the total sells and buys for the day and the difference is only approx £26k. I was putting in dummy buys from £15k down and could only get a trade at £1k so you tell me and that was offered at 6.985p.

I'm invested long term here so will ride any silly antics out and add when I think it bottoms. A good time to consider and entry over next few weeks as we all know that FDA approval will come out of the blue and then things will change. Alsoif another uk NHS region to sign up for lipidincode it could mean another £50K/ month in revenue.

Let me know what you think? Cheers Swissy

Good morning Guys, just a quick update on Genincode after presentation yesterday available on investor meet company.

Revenues of 2.2 million is very positive with first revenues coming in from US with expansions in Europe including Italy and also in the UK were we are in advanced talks with 4 other AHSN regions for implementing LipidinCode after a successful introduction in the North East last year. FDA De Novo application has been very detailed for out first in class CardioinCode kit sales. Approval is expected in Q3 but as interesting was talk on the details of need for raising funds. Matthew Walls said that we are pushing into a strong revenue generation period (Predominantly LipdinCode sales) and they mentioned possible collaborations or regular finance routes without the need for new share issues. Also that spending has be reigned back to £400,000/month so we have almost 12 months in hand and if required any future funding will be a very 'light touch" which is good news.

I will be adding on any pull backs as talk of 20p plus after FDA approval is widely accepted with LTH (DYOR) so this sideways period into the summer could prove a great time to assess an entry point if you are considering it. Watch the presentation and DYOR as usual, Cheers Swissy.

Yes I missed out today as I could have bought but didn't. What is your take on the late printed trades as many look like they could be sells? I will be in sub 20p in a flash if it happens tomorrow lol!

@tqhussain, I totally agree.

@donmac101 I think the investor meet presentation is tomorrow afternoon. Good strong positive revenues building so all we need is CIC Code Kit US approval and we are away! There was a mention in the RNS about reigning in on the spend currently so hopefully they are letting revenues support business activities in the short-term rather than another raise?

I any case I love the product hold the BOD in high regard and building steadily but strongly show it should be. Looking to add when I can, GLA Swissy.

I bet you haven't got the b-lls big enough to post that on the Hex BB lol but I will let you if it gets me in sub 10p. Anyway I will be watching for a BCE RNS to see if the black gold is flowing yet!